2,927
Views
29
CrossRef citations to date
0
Altmetric
Special Review: IL-6 inhibitor

AA amyloidosis – Benefits and prospects of IL-6 inhibitors

Pages 268-274 | Received 08 Aug 2018, Accepted 21 Aug 2018, Published online: 02 Oct 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

William G. Ambler, Kabita Nanda, Karen Brandt Onel & Susan Shenoi. (2022) Refractory systemic onset juvenile idiopathic arthritis: current challenges and future perspectives. Annals of Medicine 54:1, pages 1839-1850.
Read now
Ciro Romano, Sergio Esposito, Roberta Ferrara & Giovanna Cuomo. (2021) Tailoring biologic therapy for real-world rheumatoid arthritis patients. Expert Opinion on Biological Therapy 21:5, pages 661-674.
Read now
Reina Tsuda, Koichiro Shinoda, Ryuichi Ushijima, Makiko Nakamura, Nagaaki Katoh, Johji Imura & Kazuyuki Tobe. (2021) A case of wild-type transthyretin cardiac amyloidosis with rheumatoid arthritis. Modern Rheumatology Case Reports 5:2, pages 206-213.
Read now
Tadashi Nakamura, Naoki Shiraishi, Yasuhiro Morikami, Hiromi Fujii & Takeshi Yoshinaga. (2020) Amyloid A amyloidosis in a patient with Caplan’s syndrome, with special reference to genetic predisposition. Modern Rheumatology Case Reports 4:2, pages 212-217.
Read now

Articles from other publishers (25)

Sabine Karam, Mohamad Haidous, Virginie Royal & Nelson Leung. (2023) Renal AA amyloidosis: presentation, diagnosis, and current therapeutic options: a review. Kidney International 103:3, pages 473-484.
Crossref
Eugen Feist & Evgeny Nasonov. (2023) Interleukin 6 Inhibition in Rheumatoid Arthritis: Highlight on Olokizumab. Rheumatology 2:1, pages 17.
Crossref
Christophe Magaud, Thomas Harnois, Stephane Sebille, Aurelien Chatelier, Jean-Francois Faivre, Patrick Bois, Guylene Page & Barnabas Gellen. (2023) Pro-inflammatory cytokine secretion induced by amyloid transthyretin in human cardiac fibroblasts. Biochemical and Biophysical Research Communications 642, pages 83-89.
Crossref
Guzin Karatemiz, Sinem Nihal Esatoglu, Mert Gurcan, Yesim Ozguler, Sebahattin Yurdakul, Vedat Hamuryudan, Izzet Fresko, Melike Melikoglu, Emire Seyahi, Serdal Ugurlu, Huri Ozdogan, Hasan Yazici & Gulen Hatemi. (2023) Frequency of AA amyloidosis has decreased in Behçet’s syndrome: a retrospective study with long-term follow-up and a systematic review. Rheumatology 62:1, pages 9-18.
Crossref
Wenhu Liu, Qiang Wang, Jinxia Chang, Anup Bhetuwal, Nisha Bhattarai, Fan Zhang & Jiancai Tang. (2022) Serum proteomics unveil characteristic protein diagnostic biomarkers and signaling pathways in patients with esophageal squamous cell carcinoma. Clinical Proteomics 19:1.
Crossref
Joana Lopes, Maurício Peixoto, Eulália Antunes, Isabel Silva & Sofia Caridade. (2022) Secondary Amyloidosis and Common Variable Immunodeficiency: A Rare Association. Cureus.
Crossref
L. A. Smirnova, O. V. Simonova, E. N. Sukhikh & A. O. Shilyaeva. (2022) Case of successful use of sarilumab in secondary renal amyloidosis in a patient with rheumatoid arthritis. Rheumatology Science and Practice 60:5, pages 599-602.
Crossref
E. L. Nasonov & Eugen Feist. (2022) The prospects of interleukin-6 inhibition in rheumatoid arthritis: Olokizumab (novel monoclonal antibodies to IL-6). Rheumatology Science and Practice 60:5, pages 505-518.
Crossref
Burcu YAĞIZ, Belkıs Nihan COŞKUN, Hüseyin Ediz DALKILIÇ & Yavuz PEHLİVAN. (2022) Kronik Böbrek Hastalığı Olan Romatoid Artrit Hastalarında Biyolojik Tedavi Kullanımı: Tek Merkezli Retrospektif ÇalışmaUsage of Biological Therapy in Rheumatoid Arthritis Patients with Chronic Renal Failure: A Retrospective Study from a Single Center. Uludağ Üniversitesi Tıp Fakültesi Dergisi 48:2, pages 203-208.
Crossref
Jordan Thorne, David Clark, Laurette Geldenhuys, Keigan More, Amanda Vinson & Karthik Tennankore. (2022) Serum Amyloid A Protein–Associated Kidney Disease: Presentation, Diagnosis, and Management. Kidney Medicine 4:8, pages 100504.
Crossref
Shohei Iida, Takehisa Nakanishi, Fumiyasu Momose, Masako Ichishi, Kento Mizutani, Yoshiaki Matsushima, Ai Umaoka, Makoto Kondo, Koji Habe, Yoshifumi Hirokawa, Masatoshi Watanabe, Yoichiro Iwakura, Yoshihiro Miyahara, Yasutomo Imai & Keiichi Yamanaka. (2022) IL-17A Is the Critical Cytokine for Liver and Spleen Amyloidosis in Inflammatory Skin Disease. International Journal of Molecular Sciences 23:10, pages 5726.
Crossref
Satoshi Yamashita, Masao Saotome, Takeji Saitoh, Noriyoshi Ogawa & Yuichiro Maekawa. (2022) Long-term effect of tocilizumab on left ventricular hypertrophy and systolic dysfunction in AA amyloidosis with rheumatoid arthritis. Journal of Cardiology Cases 25:3, pages 177-181.
Crossref
Jakub Sikora, Tereza Kmochová, Dita Mušálková, Michal Pohludka, Petr Přikryl, Hana Hartmannová, Kateřina Hodaňová, Helena Trešlová, Lenka Nosková, Lenka Mrázová, Viktor Stránecký, Mariia Lunová, Milan Jirsa, Eva Honsová, Surendra Dasari, Ellen D. McPhail, Nelson Leung, Martina Živná, Anthony J. Bleyer, Ivan Rychlík, Romana Ryšavá & Stanislav Kmoch. (2022) A mutation in the SAA1 promoter causes hereditary amyloid A amyloidosis. Kidney International 101:2, pages 349-359.
Crossref
Sébastien Ottaviani & Bastien Léger. 2022. L'actualité Rhumatologique 2022. L'actualité Rhumatologique 2022 215 224 .
R. A. Osipyants, M. Z. Kanevskaya, N. L. Kozlovskaya, K. A. Demyanova, M. M. Saidova, A. V. Bespalova & T. Sh. Mirilashvili. (2021) Difficulties of biological therapy in the patient with active rheumatoid arthritis and secondary renal amyloidosis: A report of clinical case. Rheumatology Science and Practice 59:2, pages 225-228.
Crossref
Per Eriksson, Johan Mölne, Lina Wirestam & Christopher Sjöwall. (2021) Successful Treatment of AA Amyloidosis in Ankylosing Spondylitis Using Tocilizumab: Report of Two Cases and Review of the Literature. Frontiers in Medicine 8.
Crossref
Selina J Hein, Maximilian Knoll, Fabian Aus dem Siepen, Jennifer Furkel, Stefan Schoenland, Ute Hegenbart, Hugo A Katus, Arnt V Kristen & Mathias Konstandin. (2021) Elevated interleukin-6 levels are associated with impaired outcome in cardiac transthyretin amyloidosis. World Journal of Cardiology 13:3, pages 55-67.
Crossref
Ju-Yang Jung, Young-Bae Kim, Ji-won Kim, Chang-Hee Suh & Hyoun-Ah Kim. (2021) Biologic therapy for amyloid A amyloidosis secondary to rheumatoid arthritis treated with interleukin 6 therapy. Medicine 100:32, pages e26843.
Crossref
Masato Sawamura, Naoki Sawa, Hideomi Fujiwara, Masayuki Yamanouchi, Noriko Hayami, Akinari Sekine, Hiroki Mizuno, Eiko Hasegawa, Tatsuya Suwabe, Junichi Hoshino, Keiichi Kinowaki, Takeshi Fujii & Yoshifumi Ubara. (2020) Abatacept Improves Intractable Protein-Losing Enteropathy Secondary to AA Amyloidosis in a Patient With Rheumatoid Arthritis. Mayo Clinic Proceedings: Innovations, Quality & Outcomes 4:6, pages 815-820.
Crossref
Igor Kos, Stephan Stilgenbauer & Moritz Bewarder. (2020) Renal AA amyloidosis leading to early diagnosis and treatment of takayasu arteritis: a case report and review of the literature. Clinical Research in Cardiology 109:11, pages 1438-1441.
Crossref
D. G. Rumyantseva, E. M. Agafonova, S. O. Krasnenko, A. S. Starkova, M. M. Urumova & Sh. Erdes. (2020) Clinical features of ankylosing spondylitis in patients with secondary AA amyloidosis. Modern Rheumatology Journal 14:3, pages 45-49.
Crossref
Andreas Blesl, Florian Rainer, Marion Pollheimer, Patrizia Kump, Franziska Durchschein, Heimo Wenzl, Kathrin Eller, Peter Krisper, Wolfgang Petritsch & Christoph Högenauer. (2019) Successful Pregnancies After Regression of AA Amyloidosis by Anti-inflammatory Therapy in Chronic Active Crohn’s Disease. Digestive Diseases and Sciences 65:9, pages 2730-2734.
Crossref
Mitsuhiro Akiyama, Yuko Kaneko & Tsutomu Takeuchi. (2020) Effectiveness of tocilizumab in Behcet's disease: A systematic literature review. Seminars in Arthritis and Rheumatism 50:4, pages 797-804.
Crossref
Eiji Suzuki, Takashi Kanno, Ryoma Oda, Ryoichiro Kobashi, Hidemichi Imamura, Hajime Odajima, Makiko Yashiro Furuya & Kiyoshi Migita. (2020) Effectiveness of tocilizumab for Behcet disease complicated by amyloidosis in the intestinal tract. Medicine: Case Reports and Study Protocols 1:2, pages e0022.
Crossref
Sandra Ihne, Caroline Morbach, Laura Obici, Giovanni Palladini & Stefan Störk. (2019) Amyloidosis in Heart Failure. Current Heart Failure Reports 16:6, pages 285-303.
Crossref